New York University (NYU) — New York, New York

New York University (NYU) is a clinical research site located in New York, New York, United States 10012.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

New York University (NYU) has participated in 7 clinical trials with 3 currently active.

Therapeutic areas: Diabetic Macular Edema, 15q Duplication Syndrome, CDKL5 Deficiency Disease.

Sponsors: Hoffmann-La Roche, Takeda, Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York University (NYU)?

New York University (NYU) has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York University (NYU) conducted?

New York University (NYU) has 7 clinical trials on record, with 3 currently active. Their work covers Diabetic Macular Edema, 15q Duplication Syndrome, CDKL5 Deficiency Disease.

Is New York University (NYU) accredited by Crixeo Health?

New York University (NYU) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York University (NYU)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.